pharma · Chronic obstructive pulmonary disease (COPD) · Partial Epilepsy in Children and Adolescents
Bial Portela &
Bial Portela & Companhia S.A.
News and analysis for Bial Portela & on NovaPharmaNews — regulatory, clinical, and market coverage.
EU HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Programs
- 7
- Drugs
- 7
- Patents
- 3
News & analysis
NovaPharmaNews articles mentioning Bial Portela & — regulatory, clinical, and market coverage.
News and analysis for Bial Portela & on NovaPharmaNews — regulatory, clinical, and market coverage.